X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
female (11) 11
migraine (10) 10
neurosciences (10) 10
sumatriptan (10) 10
humans (9) 9
index medicus (9) 9
male (9) 9
clinical neurology (8) 8
drug therapy (7) 7
headache (7) 7
pharmacokinetics (7) 7
adult (6) 6
animals (6) 6
middle aged (6) 6
pain (6) 6
safety (6) 6
dosage and administration (5) 5
efficacy (5) 5
internal medicine (5) 5
medicine & public health (5) 5
mice (5) 5
migraine disorders - drug therapy (5) 5
neurology (5) 5
prevalence (5) 5
sumatriptan - administration & dosage (5) 5
sumatriptan - adverse effects (5) 5
astrocytes - metabolism (4) 4
double-blind method (4) 4
human necessities (4) 4
hygiene (4) 4
medical or veterinary science (4) 4
medicine (4) 4
pain medicine (4) 4
pharmacology & pharmacy (4) 4
preparations for medical, dental, or toilet purposes (4) 4
research (4) 4
spinal cord - metabolism (4) 4
subcutaneous sumatriptan (4) 4
treatment outcome (4) 4
vasoconstrictor agents - administration & dosage (4) 4
vasoconstrictor agents - adverse effects (4) 4
white matter (4) 4
aged (3) 3
analysis (3) 3
autoinjector (3) 3
burden (3) 3
care and treatment (3) 3
dementia (3) 3
dose-response relationship, drug (3) 3
drug dosages (3) 3
episodic migraine (3) 3
human factors (3) 3
immunohistochemistry - methods (3) 3
injections, subcutaneous (3) 3
original research (3) 3
psychiatry (3) 3
rats (3) 3
research article (3) 3
severity of illness index (3) 3
spinal cord - cytology (3) 3
tolerability (3) 3
validation (3) 3
young adult (3) 3
absorption (2) 2
acute treatment (2) 2
administration, intranasal (2) 2
aged, 80 and over (2) 2
alzheimer disease - drug therapy (2) 2
alzheimer's disease (2) 2
anesthesiology and pain medicine (2) 2
arachidonic acid - metabolism (2) 2
area under curve (2) 2
article (2) 2
axons (2) 2
bioavailability (2) 2
cardiovascular system (2) 2
cholinesterase inhibitors - administration & dosage (2) 2
cholinesterase inhibitors - adverse effects (2) 2
cholinesterase-inhibitors (2) 2
clinical trials (2) 2
clinical-practice (2) 2
cognitive disorders (2) 2
complications and side effects (2) 2
cross-over studies (2) 2
ddm (2) 2
disease models, animal (2) 2
double-blind (2) 2
electrocardiography (2) 2
encephalomyelitis, autoimmune, experimental - pathology (2) 2
experimental allergic encephalomyelitis (2) 2
experimental autoimmune encephalomyelitis (2) 2
food (2) 2
glial fibrillary acidic protein - metabolism (2) 2
glial-cells (2) 2
guidelines (2) 2
headaches (2) 2
health aspects (2) 2
immunocytochemical localization (2) 2
immunohistochemistry (2) 2
indans - administration & dosage (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Therapeutics, ISSN 0149-2918, 2010, Volume 32, Issue 7, pp. 1234 - 1251
Journal Article
Journal Article
Headache: The Journal of Head and Face Pain, ISSN 0017-8748, 05/2018, Volume 58, Issue 5, pp. 676 - 687
ObjectiveThe objective of this study was to evaluate the efficacy, safety, and tolerability of DFN-02 a nasal spray comprising sumatriptan 10 mg and a... 
intranasal | migraine | acute treatment | sumatriptan | permeation enhancer | METAANALYSIS | SAFETY | RATIONALE | ZOLMITRIPTAN | PREVALENCE | SUBCUTANEOUS SUMATRIPTAN | CLINICAL NEUROLOGY | PHARMACOKINETICS | HEADACHE | TOLERABILITY | Care and treatment | Pain | Drug therapy | Sumatriptan | Migraine | Analysis
Journal Article
Journal Article
The Journal of Headache and Pain, ISSN 1129-2369, 12/2018, Volume 19, Issue 1, pp. 1 - 8
Journal Article
Headache: The Journal of Head and Face Pain, ISSN 0017-8748, 05/2018, Volume 58, Issue 5, pp. 676 - 687
Journal Article
Journal Article
Journal Article
CNS DRUGS, ISSN 1172-7047, 04/2019, Volume 33, Issue 4, pp. 375 - 382
BackgroundThe commercial formulation of sumatriptan nasal spray is an effective option for migraine patients requiring or preferring a non-oral route of drug... 
PHARMACOKINETICS | EFFICACY | HEADACHE | PSYCHIATRY | TOLERABILITY | GUIDELINES | VALIDATION | PATTERNS | PHARMACOLOGY & PHARMACY | QUESTIONNAIRE | REVISED PATIENT PERCEPTION | CLINICAL NEUROLOGY
Journal Article
Medical Devices: Evidence and Research, ISSN 1179-1470, 05/2016, Volume 9, pp. 131 - 137
Migraine pain relief is reported by more than 50% of patients who receive low dose (3 mg) of sumatriptan. Currently, there is no two-step autoinjector of... 
Pain relief | Subcutaneous injection | Triptan | Preference | Usability | Usability testing | Migraine | Design | Medical equipment | Pain | Cognitive ability | Headaches | Diabetes | Drug dosages | Food
Journal Article
Journal Article
Journal Article